Feedback regulation of human immunodeficiency virus type 1 expression by the Rev protein

Rev is an essential regulatory protein of the human immunodeficiency virus type 1 (HIV-1) that affects the transport and half-life of certain viral mRNAs. Rev exerts its function via a unique element, the Rev-responsive element (RRE), located within the env region of HIV-1. It has been previously demonstrated that Rev affects the relative levels of RRE-containing and RRE-lacking mRNAs. We have studied the effects of Rev on the expression of the three different groups of small, multiply spliced mRNAs that lack the RRE sequence and encode the regulatory proteins Tat, Rev, and Nef. To monitor the tat, rev, and nef mRNAs we generated specific S1 nuclease mapping probes that distinguish among them. Analysis of all the mRNA species producing Tat, Rev, and Nef revealed that their levels are coordinately regulated by Rev. They are increased in the absence of Rev protein and are down regulated in the presence of Rev. The corresponding proteins were measured by immunoprecipitations, and their levels are in agreement with the RNA levels. These results verify the model proposing that Rev is a general regulator indirectly affecting all the multiply spliced mRNAs to a similar extent. Therefore, Rev down regulates its own expression and the expression of Tat and Nef.

[1]  E. Fenyö,et al.  Cloning and functional analysis of multiply spliced mRNA species of human immunodeficiency virus type 1 , 1990, Journal of virology.

[2]  G. Pavlakis,et al.  A novel human immunodeficiency virus type 1 protein, tev, shares sequences with tat, env, and rev proteins , 1990, Journal of virology.

[3]  M. Malim,et al.  Nef protein of human immunodeficiency virus type 1: evidence against its role as a transcriptional inhibitor. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[4]  G. Pavlakis,et al.  Cross-activation of the Rex proteins of HTLV-I and BLV and of the Rev protein of HIV-1 and nonreciprocal interactions with their RNA responsive elements. , 1989, The New biologist.

[5]  W C Greene,et al.  Comparative analysis of the HTLV-I Rex and HIV-1 Rev trans-regulatory proteins and their RNA response elements. , 1989, Genes & development.

[6]  D. Baltimore,et al.  Temporal aspects of DNA and RNA synthesis during human immunodeficiency virus infection: evidence for differential gene expression , 1989, Journal of virology.

[7]  N. Ahmad,et al.  Rev-induced modulation of Nef protein underlies temporal regulation of human immunodeficiency virus replication. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[8]  M. Emerman,et al.  The rev gene product of the human immunodeficiency virus affects envelope-specific RNA localization , 1989, Cell.

[9]  M. Hammarskjöld,et al.  Regulation of human immunodeficiency virus env expression by the rev gene product , 1989, Journal of virology.

[10]  S. Le,et al.  The HIV-1 rev trans-activator acts through a structured target sequence to activate nuclear export of unspliced viral mRNA , 1989, Nature.

[11]  G. Pavlakis,et al.  The rev (trs/art) protein of human immunodeficiency virus type 1 affects viral mRNA and protein expression via a cis-acting sequence in the env region , 1989, Journal of virology.

[12]  L. Ratner,et al.  Human immunodeficiency virus type 1 negative factor is a transcriptional silencer. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[13]  S. Josephs,et al.  Missense mutations in an infectious human immunodeficiency viral genome: functional mapping of tat and identification of the rev splice acceptor. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[14]  M. Malim,et al.  Functional replacement of the HIV-1 rev protein by the HTLV-1 rex protein , 1988, Nature.

[15]  M. Yoshida,et al.  Two cis-acting elements responsible for posttranscriptional trans-regulation of gene expression of human T-cell leukemia virus type I. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[16]  S. Venkatesan,et al.  Nef protein of HIV-1 is a transcriptional repressor of HIV-1 LTR. , 1988, Science.

[17]  M. Malim,et al.  Immunodeficiency virus rev trans-activator modulates the expression of the viral regulatory genes , 1988, Nature.

[18]  B. Franza,et al.  The Control of Human Retrovirus Gene Expression , 1988 .

[19]  A. Skalka,et al.  cis-acting intron mutations that affect the efficiency of avian retroviral RNA splicing: implication for mechanisms of control , 1988, Journal of virology.

[20]  J. Sodroski,et al.  Intragenic cis-acting art gene-responsive sequences of the human immunodeficiency virus. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[21]  Mitsuaki,et al.  Post‐transcriptional regulator (rex) of HTLV‐1 initiates expression of viral structural proteins but suppresses expression of regulatory proteins. , 1988, The EMBO journal.

[22]  G. Pavlakis,et al.  A quantitative bioassay for HIV-1 based on trans-activation. , 1988, Science.

[23]  D. Bolognesi,et al.  Human retroviruses, cancer and aids: Approaches to prevention and therapy , 1988 .

[24]  J. Sodroski,et al.  Cis-acting sequences responsive to the rev gene product of the human immunodeficiency virus. , 1988, Journal of acquired immune deficiency syndromes.

[25]  B. Cullen,et al.  Trans-activation of human immunodeficiency virus gene expression is mediated by nuclear events. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[26]  L. Jagodzinski,et al.  New human and simian HIV-related retroviruses possess functional transactivator (tat) gene , 1987, Nature.

[27]  M. Yoshida,et al.  Transcriptional (p40x) and post-transcriptional (p27x-III) regulators are required for the expression and replication of human T-cell leukemia virus type I genes. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[28]  C. Cheng‐Mayer,et al.  Mutational analysis of the human immunodeficiency virus: the orf-B region down-regulates virus replication. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[29]  D. Capon,et al.  Regulation of mRNA accumulation by a human immunodeficiency virus trans-activator protein , 1987, Cell.

[30]  L. Jagodzinski,et al.  Complete nucleotide sequences of functional clones of the AIDS virus. , 1987, AIDS research and human retroviruses.

[31]  L. Jagodzinski,et al.  Complete nucleotide sequences of functional clones of the virus associated with the acquired immunodeficiency syndrome, HTLV-III/LAV. , 1987, Haematology and blood transfusion.

[32]  P. Luciw,et al.  Elevated levels of mRNA can account for the trans-activation of human immunodeficiency virus. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[33]  G. Pavlakis,et al.  Expression and characterization of the trans-activator of HTLV-III/LAV virus. , 1986, Science.

[34]  Bryan R. Cullen,et al.  Trans-activation of human immunodeficiency virus occurs via a bimodal mechanism , 1986, Cell.

[35]  M. Feinberg,et al.  HTLV-III expression and production involve complex regulation at the levels of splicing and translation of viral RNA , 1986, Cell.

[36]  J. Ghrayeb,et al.  Expression of the protein encoded by the 3' open reading frame of human T-cell lymphotropic virus type III in bacteria: demonstration of its immunoreactivity with human sera. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[37]  J. Sodroski,et al.  A second post-transcriptional trans-activator gene required for HTLV-III replication , 1986, Nature.

[38]  J. Sodroski,et al.  The trans-activator gene of the human T cell lymphotropic virus type III is required for replication , 1986, Cell.

[39]  M. Gonda,et al.  The trans-activator gene of HTLV-III is essential for virus replication , 1986, Nature.

[40]  G. Pavlakis,et al.  The pX protein of HTLV-I is a transcriptional activator of its long terminal repeats. , 1985, Science.

[41]  Amanda G. Fisher,et al.  A molecular clone of HTLV-III with biological activity , 1985, Nature.

[42]  S. Arya,et al.  Trans-activator gene of human T-lymphotropic virus type III (HTLV-III). , 1985, Science.

[43]  J. Sodroski,et al.  The location of cis-acting regulatory sequences in the human T cell lymphotropic virus type III (HTLV-III/LAV) long terminal repeat , 1985, Cell.

[44]  L. Lasky,et al.  Nucleic acid structure and expression of the human AIDS/lymphadenopathy retrovirus , 1985, Nature.

[45]  Mark L. Pearson,et al.  Complete nucleotide sequence of the AIDS virus, HTLV-III , 1985, Nature.

[46]  R. F. Weaver,et al.  Mapping of RNA by a modification of the Berk-Sharp procedure: the 5' termini of 15 S beta-globin mRNA precursor and mature 10 s beta-globin mRNA have identical map coordinates. , 1979, Nucleic acids research.

[47]  P. Sharp,et al.  Sizing and mapping of early adenovirus mRNAs by gel electrophoresis of S1 endonuclease-digested hybrids , 1977, Cell.

[48]  A. van der Eb,et al.  A new technique for the assay of infectivity of human adenovirus 5 DNA. , 1973, Virology.

[49]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.